Validation Data Gallery
Tested Applications
Positive IHC detected in | human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
26084-1-AP targets RNF217 in IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | RNF217 fusion protein Ag22022 相同性解析による交差性が予測される生物種 |
Full Name | ring finger protein 217 |
Calculated molecular weight | 275 aa, 32 kDa |
Observed molecular weight | 59, 32 kDa |
GenBank accession number | BC026087 |
Gene Symbol | RNF217 |
Gene ID (NCBI) | 154214 |
RRID | AB_3085839 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | Q8TC41 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
E3 ubiquitin-protein ligase RNF217, also known as IBR domain-containing protein 1 (IBRDC1), as a transmembrane (TM) domain-containing RBR-type E3 ubiquitin-protein ligase, belongs to a highly conserved member of the RING finger family. RNF217 mediates the degradation of the iron exporter ferroportin/SLC40A1 and thus regulates iron homeostasis(Uniprot, PMID: 33895792).
Protocols
Product Specific Protocols | |
---|---|
IHC protocol for RNF217 antibody 26084-1-AP | Download protocol |
IF protocol for RNF217 antibody 26084-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |